[1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1):7-30.
|
[2] |
Abdollah F, Gandaglia G, Thuret R, et al. Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis[J]. Cancer Epidemiol, 2013, 37(3):219-225.
|
[3] |
Aldousari S, Kassouf W. Update on the management of non-muscle invasive bladder cancer[J]. Can Urol Assoc J, 2010,4(1):56-64.
|
[4] |
Dołowy A, Krajewski W, Dembowski J, et al. The role of lasers in modern urology[J]. Cent European J Urol, 2015, 68(2):175-182.
|
[5] |
张翼飞,梁朝朝,施浩强,等.整块剜除术治疗非肌层浸润性膀胱肿瘤[J/CD].中华腔镜泌尿外科杂志:电子版, 2016(6):379-382.
|
[6] |
Saito S. Transurethral en bloc resection of bladder tumors[J]. J Urol, 2001, 166(6):2148-2150.
|
[7] |
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group[J]. JAMA, 2000, 283(15):2008-2012.
|
[8] |
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration[J]. PLoS Med, 2009, 6(7):e1000100.
|
[9] |
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample[J]. BMC Med Res Methodol, 2005, 5(1):13.
|
[10] |
侯祺,黄文涛,李茂胤,等.微通道经皮肾镜与输尿管软镜治疗肾结石有效性和安全性的meta分析[J/CD].中华腔镜泌尿外科杂志:电子版, 2015, 9(3):29-32.
|
[11] |
Migliari R, Buffardi A, Ghabin H. Thulium laser endoscopic En bloc enucleation of Nonmuscle-Invasive bladder cancer[J]. J Endourol, 2015, 29(11):1258-1262.
|
[12] |
Muraro GB, Grifoni R, Spazzafumo L. Endoscopic therapy of superficial bladder cancer in high-risk patients: Holmium laser versus transurethral resection[J]. Surg Technol Int, 2005, 14(14):222-226.
|
[13] |
Tao W, Yang D, Shan Y, et al. Safety and efficacy of 120W high performance system greenlight laser vaporization for non-muscle-invasive bladder cancer[J]. J Xray Sci Technol, 2013, 21(2):309-316.
|
[14] |
Yang D, Xue B, Zang Y, et al. Efficacy and safety of potassium-titanyl- phosphate laser vaporization for clinically non-muscle invasive bladder cancer[J]. Urol J, 2014, 11(1):1258-1263.
|
[15] |
Zhu YF, Jiang XZ, Zhang JP, et al. Safety and efficacy of Holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience[J]. Urology, 2008, 72(3):608-612.
|
[16] |
Chen X, Liao J, Chen L, et al. En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial[J]. World J Urol, 2015, 33(7):989-995.
|
[17] |
Liu H, Wu J, Xue S, et al. Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer[J]. J Int Med Res, 2013, 41(4):984-992.
|
[18] |
Xu Y, Guan W, Chen W, et al. Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: A prospective, randomized study[J]. Lasers Surg Med, 2015, 47(4):306-311.
|
[19] |
Zhang XR, Feng C, Zhu WD, et al. Two micrometer continuous-wave thulium laser treating primary non-muscle- invasive bladder cancer: is it feasible? a randomized prospective study[J]. Photomed Laser Surg, 2015, 33(10):517-523.
|